Literature DB >> 27932358

Association between lower limb osteoarthritis and incidence of depressive symptoms: data from the osteoarthritis initiative.

Nicola Veronese1,2, Brendon Stubbs3,4,5, Marco Solmi2,6,7, Toby O Smith8, Marianna Noale9, Cyrus Cooper10,11,12, Stefania Maggi9.   

Abstract

Background: osteoarthritis (OA) is associated with a number of medical morbidities. Although the prevalence of depression and depressive symptoms is presumed to be high in people with OA, no prospective comparative study has analyzed its incidence. Objective: to determine whether OA was associated with an increased odds of developing depressive symptoms. Design: longitudinal cohort study (follow-up: 4.2 years). Setting: data were gathered from the North American Osteoarthritis Initiative (OAI) dataset. Subjects: people at higher risk developing OA.
Methods: OA diagnosis was defined as the presence of OA at hand, knee, hip, back/neck or other sites at baseline. Depressive symptoms were defined using the 20-item Center for Epidemiologic Studies-Depression (cut-off 16 points) after 4 years.
Results: a total of 3,491 people without depressive symptoms at baseline were analyzed (1,506 with OA/1,985 without). Using an adjusted logistic regression analysis for 12 potential confounders, people with OA had a similar odds of depressive symptoms at follow-up compared to those without OA (odds ratio (OR): 1.26; 95% confidence of interval (CI): 0.95-1.67). However, multi-site OA (i.e. OA ≥2 sites; OR: 1.48, 95% CI: 1.07-2.05) and the specific presence of hip (OR: 1.72; 95% CI: 1.08-2.73) or knee OA (OR: 1.43; 95% CI: 1.03-1.98) were associated with a greater odds of developing depressive symptoms compared to people without OA. Conclusions: this is the first study of longitudinal data to demonstrate people with multi-site, hip or knee OA have a greater odds of developing depressive symptoms compared to people without OA. This suggests that OA may be associated with future mental health burden.
© The Author 2016. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  depression; depressive symptoms; epidemiology, older people; osteoarthritis

Mesh:

Year:  2017        PMID: 27932358     DOI: 10.1093/ageing/afw216

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  33 in total

1.  Effects of Osteoarthritis Pain and Concurrent Insomnia and Depression on Health Care Use in a Primary Care Population of Older Adults.

Authors:  Minhui Liu; Susan M McCurry; Basia Belza; Adrian Dobra; Diana T Buchanan; Michael V Vitiello; Michael Von Korff
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-05-10       Impact factor: 4.794

2.  Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years.

Authors:  Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Marco Solmi; Michele Fornaro; Brisa S Fernandes; Christoph Mueller; Trevor Thompson; André F Carvalho; Stefania Maggi
Journal:  Int J Geriatr Psychiatry       Date:  2017-08-06       Impact factor: 3.485

Review 3.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

Review 4.  Nanotechnological approach and bio-inspired materials to face degenerative diseases in aging.

Authors:  Anna Tampieri; Monica Sandri; Michele Iafisco; Silvia Panseri; Monica Montesi; Alessio Adamiano; Massimiliano Dapporto; Elisabetta Campodoni; Samuele M Dozio; Lorenzo Degli Esposti; Simone Sprio
Journal:  Aging Clin Exp Res       Date:  2019-10-08       Impact factor: 3.636

5.  Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America.

Authors:  Nicola Veronese; Brendon Stubbs; Marco Solmi; Alberto Vaona; Jacopo Demurtas; Andre F Carvalho; Ai Koyanagi; Trevor Thompson; Mario Zoratti; Stefania Maggi
Journal:  J Affect Disord       Date:  2017-04-04       Impact factor: 4.839

6.  Osteoarthristis Increases the Risk of Cardiovascular Disease: Data from the Osteoarthritis Initiative.

Authors:  N Veronese; B Stubbs; M Solmi; T O Smith; J-Y Reginster; S Maggi
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

7.  Psychological and Pain Sensitization Characteristics Are Associated With Patellofemoral Osteoarthritis Symptoms: The Multicenter Osteoarthritis Study.

Authors:  Natalie J Collins; Tuhina Neogi; Bill Vicenzino; Ali Guermazi; Frank W Roemer; Cora E Lewis; James C Torner; Michael C Nevitt; Joshua J Stefanik
Journal:  J Rheumatol       Date:  2020-03-01       Impact factor: 4.666

8.  Effects of Pain, Insomnia, and Depression on Psychoactive Medication Supply in Older Adults With Osteoarthritis.

Authors:  Minhui Liu; Susan M McCurry; Basia Belza; Diana T Buchanan; Adrian Dobra; Michael Von Korff; Michael V Vitiello
Journal:  Med Care       Date:  2018-12       Impact factor: 2.983

9.  Association Between Osteoarthritis and Social Isolation: Data From the EPOSA Study.

Authors:  Paola Siviero; Nicola Veronese; Toby Smith; Brendon Stubbs; Federica Limongi; Sabina Zambon; Elaine M Dennison; Mark Edwards; Cyrus Cooper; Erik J Timmermans; Natasja M van Schoor; Suzan van der Pas; Laura A Schaap; Michael D Denkinger; Richard Peter; Florian Herbolsheimer; Ángel Otero; Maria Victoria Castell; Nancy L Pedersen; Dorly J H Deeg; Stefania Maggi
Journal:  J Am Geriatr Soc       Date:  2019-09-17       Impact factor: 5.562

Review 10.  Current Models for Development of Disease-Modifying Osteoarthritis Drugs.

Authors:  Meagan J Makarczyk; Qi Gao; Yuchen He; Zhong Li; Michael S Gold; Mark C Hochberg; Bruce A Bunnell; Rocky S Tuan; Stuart B Goodman; Hang Lin
Journal:  Tissue Eng Part C Methods       Date:  2021-02-04       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.